The Verisyse Refractive Intraocular Lens (IOL) Implant was approved by the FDA in September 2004.

Verisyse Refractive IOL

The refractive or phakic lens implant procedure is recommended for patients who do not qualify for LASIK due to severe nearsightedness, farsightedness, or cases where the cornea is too thin for LASIK. In the past, a clear lensectomy with a lens replacement implant might have been performed (usually in cataract surgery), removing the ability to read up close for patients under age 40. Because your own natural lens is left in place, the phakic lens implant retains your lens? natural ability to read up close and adjust for objects farther away.
The Verisyse lens has been implanted in over 150,000 eyes in Europe, with a 60% implantation rate compared to all other phakic IOLs, over the past 18 years. It is composed of the same plastic material that has been used in lens implants for more than 30 years. The lens is easily inserted and if necessary, can be easily removed, making the entire procedure reversible. This outpatient procedure requires mild sedation and is performed in approximately 10-15 minutes.

How Verisyse Works

The procedure involves placing the Verisyse Refractive IOL behind your cornea and on top of your iris. This gives your eye another focusing lens that provides high-quality, high-definition vision like a normal eye. Although the Verisyse Phakic IOL is intended to be permanent, the procedure is reversible if desired. Leaving your natural crystalline lens in place is important because of its important role in helping your eye adjust between seeing objects that are near and far.